Catalysts for $TERN
21 tracked
May 7, 2026
earnings
Terns Pharmaceuticals, Inc. earnings
Terns Pharmaceuticals, Inc.
→
Apr 15, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 15, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 15, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 15, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 15, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 1, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 1, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Apr 1, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Mar 27, 2026
approval
PONLIMSI (DENOSUMAB-ADET) — FDA approval
PONLIMSI
→
Mar 11, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Mar 11, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Mar 11, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Mar 11, 2026
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Dec 10, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls III)
Terns Pharmaceuticals, Inc.
→
Nov 12, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Nov 5, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Nov 5, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Nov 5, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Jul 2, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→
Feb 12, 2025
recall
Teva Pharmaceuticals USA, Inc recall (Cls II)
Terns Pharmaceuticals, Inc.
→